- Corporate
- The share
- Press releases
- Financial calendar
- Financial reports
- Financial reports – ESEF
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Environmental Policy
- Code of Conduct for Suppliers
- Policy on anti-corruption, gifts and hospitality
- Privacy policy
- Contact us
- Subscribe
- Thank you
- Error
XVIVO Capital Markets Day 2022
XVIVOs digital Capital Markets Day was held September 21, 2022. Dag Andersson, CEO, and members of the XVIVO management team covered company strategy, financials and operations momentum. Dr. David McGiffin, Australia, joined as a guest speaker. He presented his experience with the XVIVO Heart technology as the coordinating principal investigator of the ANZ NIHP clinical trial.
XVIVO Capital Markets Day 2021
XVIVO’s Capital Markets Day was held on September 23, 2021 at GoCo Health Innovation City in Gothenburg. Dag Andersson, CEO and members of the XVIVO management team covered company strategy, objectives and took deep dives into key projects and innovative technologies.
The event also included sections with external guests, including Filip Rega, Professor Dr at University Hospitals Leuven and the principal investigator of XVIVOs European Heart preservation study, Brandi Zofkie, Director and Ex Vivo Lung Specialist at Lung Bioengineering and Muhammad M. Mohiuddin, Professor of Surgery and Director of the Cardiac Xenotransplantation program at University of Maryland School of Medicine. The Capital Markets Day was moderated by financial analyst and journalist, Lars Frick.
